Welcome to visit Hefei Kangchuntang Pharmaceutical Co., Ltd!

中文版 中文版  |   英文版 英文版
Manager
OA Login

Contact Us

Hefei Kangchuntang Pharmaceutical Co., Ltd.
Address: No.13, Branch Road, Biomedical Park, High-tech Zone, Hefei City, Anhui Province
Telephone:86551-63830999/63673366

Hefei High-tech Zone: "Smart Pharmacy" Makes Traditional Chinese Medicine More Accessible

2022-11-08 08:53

In May 2022, the Anhui Provincial Health Commission, the Provincial Development and Reform Commission, and the Provincial Administration of Traditional Chinese Medicine jointly issued the "Anhui Province's 14th Five-Year Plan for the Development of Traditional Chinese Medicine." The document states that it will strongly support the construction of an information platform for traditional Chinese medicine and the development of intelligent traditional Chinese medicine medical services. As a representative of traditional national quintessence, how is traditional Chinese medicine connected with keywords such as "informationization" and "intelligent platform"? How can advanced technology be used to empower the traditional Chinese medicine industry and benefit the people? With these questions in mind, the reporter visited Kangchuntang Pharmaceutical Co., Ltd., located in Hefei High-tech Zone.

Anhui Province Issues Action Plan to Promote the Revitalization and Development of Traditional Chinese Medicine

2022-05-14 14:33

To fully leverage the unique strengths of Anhui Province's traditional Chinese medicine (TCM), known as "Bei Huatuo and Nan Xin'an," accelerate the construction of a leading TCM province nationwide, and strive to be a pioneer in leading the development of TCM, the Anhui Provincial People's Government recently issued the Action Plan for Promoting the Revitalization and Development of Traditional Chinese Medicine in Anhui Province (2022-2024).

Announcement on the Conclusion of the Pilot Program for Traditional Chinese Medicine Compound Granules

2021-03-02 10:41

To strengthen the management of traditional Chinese medicine (TCM) formula granules, standardize their production, guide the healthy development of the industry, and better meet the clinical needs of TCM, it has been decided to conclude the pilot program for TCM formula granules.

Major Policy Document on Traditional Chinese Medicine! The General Office of the State Council Issues a Notice on Several Policy Measures to Accelerate the Characteristic Development of Traditional Chinese Medicine

2021-03-02 10:13

Since the 18th National Congress of the Communist Party of China, the Party Central Committee with Comrade Xi Jinping at its core has placed traditional Chinese medicine (TCM) work in a prominent position, and TCM reform and development have achieved remarkable results. After the outbreak of the COVID-19 epidemic, TCM participated comprehensively in epidemic prevention and control and treatment, making important contributions. However, it must also be recognized that TCM still suffers to some extent from insufficient high-quality supply, insufficient number of talents, imperfect innovation system, and lack of prominent characteristics. We must adhere to Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era, fully implement the spirit of the 19th National Congress of the Communist Party of China and the second, third, fourth, and fifth plenary sessions of the 19th Central Committee, further implement the Opinions of the Central Committee of the Communist Party of China and the State Council on Promoting the Inheritance and Innovation Development of TCM and the deployment of the National TCM Conference, follow the laws of TCM development, carefully summarize the experience and practices of TCM in preventing and treating COVID-19, solve existing problems, better play the characteristics and comparative advantages of TCM, and promote the mutual supplementation and coordinated development of TCM and Western medicine.

National Medical Products Administration Center for Drug Evaluation's Announcement on the Release of the 'Technical Guidelines for Pharmacological Research at Each Stage of the Development of New Traditional Chinese Medicines (Trial)' (No. 37, 2020)

2020-11-06 09:40

Under the guidance of the National Medical Products Administration (NMPA), the Center for Drug Evaluation (CDE) has formulated the "Technical Guidelines for Pharmaceutical Research at Various Stages of New Traditional Chinese Medicine Drug Research (Trial Implementation)" (see attachment). In accordance with the requirements of the "Notice on the Issuance of the Release Procedure for Pharmaceutical Technical Guidelines" (Yaojianzongyao Guan [2020] No. 9) issued by the Comprehensive Department of the NMPA, and after review and approval by the NMPA, these guidelines are hereby released and shall come into effect from the date of release.

Notice of the National Administration of Traditional Chinese Medicine on Issuing the Implementation Plan for the Support Program of Innovative Teams and Talents in Traditional Chinese Medicine

2020-11-06 09:37

To implement the Opinions of the Central Committee of the Communist Party of China and the State Council on Promoting the Inheritance and Innovation Development of Traditional Chinese Medicine, promote the construction of multidisciplinary cross-innovation teams in Traditional Chinese Medicine, and cultivate a group of young and middle-aged multidisciplinary cross-innovation talents, our bureau has decided to launch the Traditional Chinese Medicine Innovation Team and Talent Support Program.

Notice on Issuing the National Influenza Prevention and Control Work Plan (2020 Edition)

2020-10-09 10:45

To further improve the prevention and control of influenza during the 2020-2021 influenza season, the National Joint Prevention and Control Mechanism of the State Council for the Novel Coronavirus Pneumonia Epidemic has formulated the National Influenza Prevention and Control Work Plan (2020 Edition). This is now issued to you, please organize and implement it seriously. If you have any suggestions during the implementation process, please promptly feedback to the mechanism's comprehensive group.

Notice from the Center for Drug Evaluation of the National Medical Products Administration on the Release of the 'Technical Guiding Principles (Trial) on Real-World Research Supporting Children's Drug R&D and Review'

2020-09-04 14:40

Considering the actual needs of children's drug research and development and drug registration in our country, and to help enterprises better understand the application of the "Guiding Principles for Drug Research and Development and Review Supported by Real-World Evidence (Trial Implementation)" in children's drug research and development, under the deployment of the National Medical Products Administration, the Center for Drug Evaluation organized the formulation of the "Technical Guiding Principles for Real-World Research Supporting Children's Drug Research and Development and Review (Trial Implementation)" (see Appendix). In accordance with the requirements of the "Notice on Issuing the Procedures for Issuing Drug Technical Guiding Principles" (Pharmaceutical Supervision and Administration [2020] No. 9) issued by the Comprehensive Department of the National Medical Products Administration, and with the approval of the National Medical Products Administration, this is now issued and shall come into force from the date of its issuance.

Notice on Issuing Technical Specifications for COVID-19 Nucleic Acid 10-in-1 Mixed Sample Testing

2020-08-31 15:27

Joint Prevention and Control Mechanisms (Leading Groups, Command Headquarters) of all provinces, autonomous regions, municipalities directly under the Central Government, and the Xinjiang Production and Construction Corps for COVID-19: In order to guide local areas in carrying out COVID-19 mixed sample testing, further improve the capacity and efficiency of COVID-19 nucleic acid testing, implement the “four early” requirements, and effectively meet the needs of normalized epidemic prevention and control, we have developed the “Technical Specifications for COVID-19 Nucleic Acid 10-in-1 Mixed Sample Testing”.

People's Daily: Awakening the Sleeping Classic Prescriptions of Traditional Chinese Medicine

2020-08-19 10:25

On June 2, General Secretary Xi Jinping emphasized at an expert and scholar symposium: "We must strengthen the combing and excavation of the essence of classical medical texts, build a number of scientific research support platforms, reform and improve the review and approval mechanism for traditional Chinese medicine, and promote the research and development and industrial development of new traditional Chinese medicines."

< 123456 >